Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wells Fargo Maintains Equal-Weight on Southern, Lowers Price Target to $72

Wells Fargo Maintains Equal-Weight on Southern, Lowers Price Target to $72

Wells Fargo analyst Neil Kalton maintains Southern (NYSE:SO) with a Equal-Weight and lowers the price target from $80 to $72.

October 6, 2022

1 minute read

Wells Fargo analyst Neil Kalton maintains Southern (NYSE:SO) with a Equal-Weight and lowers the price target from $80 to $72.

Amicus Therapeutics Drug Scores FDA Approval For Rare Inherited Pompe Disease

September 28, 12:41 PM

The FDA has approved Amicus Therapeutics' (NASDAQ: FOLD) Pombiliti (cipaglucosidase alfa-atga)+Opfolda (miglustat) 65mg capsules for Pompe disease.

February 28, 9:28 AM

This week, Tesla Inc (NASDAQ: TSLA) is hosting its "Investor Day." In early February, CEO Elon Musk tweeted hints at what we can expect.

April 12, 3:01 PM

Analysts have provided the following ratings for LGI Homes (NASDAQ:LGIH) within the last quarter: Bullish Somewhat Bullish Indifferent…

September 13, 11:48 AM

Beleaguered crypto exchange FTX (CRYPTO: FTT) has revised its plan to liquidate billions in cryptocurrency holdings.